Citigroup Inc Cyteir Therapeutics, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$1.18 - $1.76 $499 - $744	-423 Reduced 63.23%	246 $0
Q3 2022 Nov 10, 2022	SELL	$1.99 - $4.05 $529 - $1,077	-266 Reduced 28.45%	669 $1,000
Q2 2022 Aug 10, 2022	SELL	$1.62 - $4.4 $882 - $2,398	-545 Reduced 36.82%	935 $3,000
Q1 2022 May 12, 2022	SELL	$3.39 - $10.51 $5,637 - $17,478	-1,663 Reduced 52.91%	1,480 $6,000
Q4 2021 Feb 10, 2022	BUY	$9.83 - $19.21 $18,883 - $36,902	1,921 Added 157.2%	3,143 $36,000
Q3 2021 Nov 10, 2021	BUY	$14.57 - $21.86 $17,804 - $26,712	1,222 New	1,222 $21,000

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.